NCRP

SALLY A. AMUNDSON

SALLY A. AMUNDSON

Amundson-S

is an Associate Professor of Radiation Oncology at the Center for Radiological Research of Columbia University Irving Medical Center in New York, where she is Co-Director of the Center for High-Throughput Minimally-Invasive Radiation Biodosimetry. She holds a doctorate in radiation biology and cancer biology from the Harvard School of Public Health. Her research uses functional genomics approaches to study low-dose radiation and bystander effects, unique effects of space radiation, the development of gene expression approaches for radiation biodosimetry, and the linear-energy transfer dependence of heavy ion radiotherapy.

Prior to joining the group at Columbia, Dr. Amundson worked on molecular radiation biology in the Division of Basic Science at the National Cancer Institute (NCI), where she helped to develop global gene expression profiling techniques, and where she was an Adjunct Investigator in the NCI Radiation Epidemiology Branch. She served on the Science Advisory Committee of the Radiation Effects Research Foundation in Hiroshima from 2009 to 2014 and on the U.S. Environmental Protection Agency Science Advisory Board’s Radiation Advisory Committee from 2015 to 2022. She has been a member of the Multidisciplinary European Low Dose Initiative (MELODI) Scientific Advisory Committee since 2016 and has served on the NCRP since 2004.

Dr. Amundson is an Associate Editor of Radiation Research, and has served on the organizing and program committees for numerous meetings, including two of the American Statistical Association Conferences on Radiation and Health, which aim to integrate radiation biology with epidemiology. She is a recipient of the Michael Fry Research Award from the Radiation Research Society (RRS), and served as President of the RRS in 2021 to 2022.